Examkin

Question

Difficulty: EasyGastroenterology and Hepatology

A 48-year-old man is evaluated on his second day of hospitalization for acute pancreatitis. He initially presented with severe epigastric pain radiating to the back, and laboratory studies on admission showed a serum lipase level of 2,400 U/L2,400\text{ U/L}. The patient has a history of heavy alcohol consumption. He has been receiving aggressive intravenous fluid resuscitation and pain management.

Currently, the patient reports some improvement in his abdominal pain. His temperature is 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, pulse is 105/min105\text{/min}, and respirations are 18/min18\text{/min}. Physical examination reveals a distended abdomen with epigastric tenderness, but no guarding or rebound tenderness. Laboratory studies show a leukocyte count of 15,500/mm315,500\text{/mm}^3. A contrast-enhanced CT scan of the abdomen demonstrates diffuse pancreatic enlargement with peripancreatic fluid collections and uniform enhancement of the pancreatic parenchyma. There is no evidence of gas within the fluid collections.

Which of the following is the most appropriate next step in management regarding pharmacotherapy?

  1. Continue current supportive care without antimicrobial therapyAnswer
  2. B
    Initiate intravenous imipenem-cilastatin
  3. C
    Initiate intravenous piperacillin-tazobactam
  4. D
    Initiate intravenous ciprofloxacin and metronidazole
  5. E
    Initiate intravenous ceftriaxone

Answer

Continue current supportive care without antimicrobial therapy
The correct answer is to continue supportive care. In the first few days of severe acute pancreatitis, patients frequently develop Systemic Inflammatory Response Syndrome (SIRS), which presents with fever, tachycardia, tachypnea, and leukocytosis. These findings represent a severe inflammatory state caused by the systemic release of pancreatic enzymes and cytokines, not an infectious process. The CT scan confirms uniform pancreatic enhancement (ruling out necrotizing pancreatitis) and absence of gas (ruling out infected necrosis). Current guidelines strongly recommend against the use of prophylactic antibiotics in acute pancreatitis, even in the presence of sterile necrosis. Antimicrobial therapy should be reserved for documented extrapancreatic infections (e.g., cholangitis, catheter-associated infections, pneumonia) or infected pancreatic necrosis (which typically occurs 2 to 4 weeks after initial presentation and is suggested by gas on CT or positive fine-needle aspiration).

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has fever, tachycardia, and leukocytosis on hospital day 2 of acute pancreatitis.
Identifying the timeline of fever helps differentiate between SIRS (early) and infected necrosis (typically >2 weeks).
2
Evaluate the diagnostic imaging.
CT scan shows uniform enhancement without gas.
Uniform enhancement indicates lack of pancreatic necrosis. Absence of gas means there is no gas-forming bacterial infection.
3
Determine the indication for antibiotics.
No antibiotics are indicated.
Fever and leukocytosis early in acute pancreatitis are due to a severe inflammatory response, not an active infection. Prophylactic antibiotics do not improve outcomes.

Key Concept

Fever and leukocytosis early in the course of acute pancreatitis are typically due to Systemic Inflammatory Response Syndrome (SIRS). Prophylactic antibiotics are contraindicated in sterile acute pancreatitis.
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic